April 13, 2023
The University of Cincinnati is enrolling patients in an Imvax study that will test the effectiveness of a personalized vaccine approach to fight deadly brain tumors.
April 14, 2023
University of Cincinnati Cancer Center researchers will present more than a dozen abstracts at the American Association for Cancer Research Annual Meeting 2023, held in Orlando, Florida, April 14-19, including findings that could advance treatments for head and neck and breast cancers.
April 14, 2023
The University of Cincinnati Cancer Center's Melinda Butsch Kovacic and colleagues will present research abstracts on several community outreach and engagement initiatives at the American Association for Cancer Research Annual Meeting 2023, held in Orlando, Florida, April 14-19.
May 9, 2023
The University of Cincinnati's Eva Mistry joined Fox 19's morning show to discuss American Stroke Month.
May 25, 2023
The University of Cincinnati's Rhonna Shatz, DO, was featured in an AARP article discussing ways to tell the difference between normal memory loss and more concerning memory problems.
May 26, 2023
The University of Cincinnati's Achala Vagal presented the results of the first large-scale assessment of radiological brain health in stroke patients in a population at the European Stroke Organization Conference 2023 in Munich, Germany.
November 29, 2022
The University of Cincinnati's Alberto Espay was featured in a Financial Times article discussing the new Alzheimer's drug lecanemab.
November 17, 2022
The Cincinnati Enquirer featured the story of Dr. Alan Jobe, a Cincinnati Children's researcher who has beaten the odds of a glioblastoma diagnosis with the help of his team of University of Cincinnati physicians.
November 21, 2022
The University of Cincinnati Cancer Center's Davendra Sohal joined 55KRC's Simply Medicine program to discuss pancreatic cancer clinical trial options and screening during Pancreatic Cancer Awareness Month.
December 21, 2023
U.S. News & World Report highlighted research led by the University of Cincinnati's Francisco Romo-Nava that found spinal cord stimulation was well tolerated and has therapeutic potential to treat depression.